======= TGIF2 =======
== Gene Information ==
* **Official Symbol**: TGIF2
* **Official Name**: TGFB induced factor homeobox 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=60436|60436]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9GZN2|Q9GZN2]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=TGIF2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TGIF2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/607294|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Transcriptional repressor, which probably repress transcription by binding directly the 5'-CTGTCAA-3' DNA sequence or by interacting with TGF-beta activated SMAD proteins. Probably represses transcription via the recruitment of histone deacetylase proteins. {ECO:0000269|PubMed:11427533}.
|Homeobox KN|
|Homeobox|
|nodal signaling pathway|
|activin receptor signaling pathway|
|regulation of gastrulation|
|regulation of embryonic development|
|retina development in camera-type eye|
|transmembrane receptor protein serine/threonine kinase signaling pathway|
|camera-type eye development|
|eye development|
|visual system development|
|positive regulation of neuron differentiation|
|sensory system development|
|positive regulation of neurogenesis|
|positive regulation of nervous system development|
|positive regulation of cell development|
|sensory organ development|
|regulation of neuron differentiation|
|DNA-binding transcription factor activity|
|enzyme linked receptor protein signaling pathway|
|regulation of neurogenesis|
|negative regulation of transcription by RNA polymerase II|
|regulation of nervous system development|
|regulation of cell development|
|positive regulation of cell differentiation|
|regulation of anatomical structure morphogenesis|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|positive regulation of developmental process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|DNA binding|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|generation of neurons|
|negative regulation of biosynthetic process|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|neurogenesis|
|negative regulation of gene expression|
|positive regulation of multicellular organismal process|
|regulation of cell differentiation|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|-1.77|
|[[:results:exp291|LLY-284 2.6μM R06 exp291]]|-1.73|
|[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|-1.72|
|[[:results:exp46|HMS-I1 1μM R01 exp46]]|1.82|
|[[:results:exp216|Erlotinib 10μM R05 exp216]]|1.87|
|[[:results:exp307|Rapamycin 2μM plus Cyclosporin-A 3μM R07 exp307]]|1.93|
|[[:results:exp126|GSK461364A 0.1μM R03 exp126]]|2.08|
|[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|2.13|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 1/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|1/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 7070
* **Expression level (log2 read counts)**: 5.51
{{:chemogenomics:nalm6 dist.png?nolink |}}